Toronto
Canada
55
2021-11-25
The entities that hold a legal rights for patent applications filed by inventor Marshall John:
John Marshall from Toronto, CA has applied for patents for these inventions. The list has both pending applications and granted patents:
Methods of treating a vascular leakage-associated disease or disorder
#2 | 2009-04-09Glycoprotein and apolipoprotein biopolymer markers predictive of Alzheimers disease
#3 | 2008-04-24Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons
#4 | 2008-01-01Biopolymer marker indicative of disease state having a molecular weight of 1562 daltons
#5 | 2007-11-13Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons
#6 | 2007-08-16Apolipoprotein biopolymer markers indicative of insulin resistance
#7 | 2007-02-08Protein biopolymer markers predictive of type II diabetes
#8 | 2007-01-11Complement C3 precursor biopolymer markers indicative of insulin resistance
#9 | 2007-01-11Protein biopolymer markers predictive of insulin resistance
#10 | 2007-01-11Apolipoprotein biopolymer marker indicative of normal human
#11 | 2007-01-04Cene-E biopolymer marker indicative of age matched control
#12 | 2006-12-28Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons
#13 | 2006-12-07Complement C3 precursor biopolymer markers predictive of type II diabetes
#14 | 2006-11-07Betaine/GABA transport protein biopolymer marker indicative of insulin resistance
#15 | 2006-09-21Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance
#16 | 2006-09-21Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance
#17 | 2006-09-21Protein biopolymer markers indicative of age matched control
#18 | 2006-09-21Protein biopolymer markers indicative of age matched control
#19 | 2006-09-21Interalpha trypsin inhibitor biopolymer markers indicative of insulin resistance
#20 | 2006-09-21Interalpha trypsin inhibitor biopolymer markers indicative of insulin resistance
#21 | 2006-09-21Protein biopolymer markers indicative of age matched control
#22 | 2006-09-21Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance
#23 | 2006-09-21Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance
#24 | 2006-09-21Protein biopolymer markers predictive of insulin resistance
#25 | 2006-09-21Protein biopolymer markers predictive of insulin resistance
#26 | 2006-09-21Protein biopolymer markers predictive of insulin resistance
#27 | 2006-09-21Protein biopolymer markers predictive of insulin resistance
#28 | 2006-09-21Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons
#29 | 2006-09-14Protein biopolymer markers predictive of insulin resistance
#30 | 2006-08-31Protein biopolymer markers predictive of type II diabetes
#31 | 2006-08-31Protein biopolymer markers indicative of insulin resistance
#32 | 2006-08-31Complement C3 precursor biopolymer markers indicative of insulin resistance
#33 | 2006-08-31Fibronectin precursor biopolymer markers indicative of alzheimer's disease
#34 | 2006-08-08Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons
#35 | 2006-07-20IG heavy chain, IG kappa, IG lambda biopolymer markers predictive of Alzheimer's disease
#36 | 2006-07-20Complement C3 precursor biopolymer markers predictive of type II diabetes
#37 | 2006-07-11Protein biopolymer markers indicative of alzheimer's disease
#38 | 2006-06-22Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance
#39 | 2006-06-22Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance
#40 | 2006-05-30Protein biopolymer markers predictive of insulin resistance
#41 | 2006-05-23Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons
#42 | 2006-04-20Biopolymer markers indicative of type II diabetes
#43 | 2006-04-11IG lambda biopolymer markers predictive of Alzheimers disease
#44 | 2006-03-30Biopolymer marker indicative of disease state having a molecular weight of 1077 daltons
#45 | 2006-03-09Fibronectin biopolymer marker indicative of insulin resistance
#46 | 2006-03-07Biopolymer marker indicative of disease state having a molecular weight of 1077 daltons
#47 | 2006-02-14Biopolymer marker indicative of disease state having a molecular weight of 1793 daltons
#48 | 2006-02-02Protein biopolymer markers predictive of alzheimer's disease
#49 | 2006-02-02Biopolymer marker indicative of disease state having a molecular weight of 1424 daltons
#50 | 2006-02-02Biopolymer marker indicative of disease state having a molecular weight of 1525 Daltons
#51 | 2005-12-29Method and kit for diagnosing myocardial infarction
#52 | 2005-12-29Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance
#53 | 2005-05-10Amino acid sequence pattern matching
#54 | 2005-05-10HP biopolymer markers predictive of insulin resistance
#55 | 2005-05-10Biopolymer marker indicative of disease state having a molecular weight of 1350 daltons
3920478 ⎘